Clinical Trial Update: Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on fexinidazole for early-stage Human African Trypanosomiasis (HAT) in T.b. gambiense, reporting efficacy and safety from a multicenter pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Human African Trypanosomiasis (HAT) | Phase 2, Phase 3 | Status: COMPLETED